Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02844621 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Proton Pump Inhibitors on Gut Microbiota and Systemic Inflammation in Older Adults
A Early Phase 1 study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 25
- Enrollment target
NCT02844621 is a Early Phase 1 study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 25 participants.
The verdict
NCT02844621, a Early Phase 1 study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of a common over-the-counter medication, omeprazole, on the normal gut bacteria and inflammation in the body in healthy older adults.
Interventions
- DRUG Omeprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2016-05 |
| Est. Completion | 2016-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02844621
The ClinicalTrials.gov registry entry for NCT02844621 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Omeprazole is the first listed.
NCT02844621 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02844621 about?
NCT02844621 is a clinical study titled "Effect of Proton Pump Inhibitors on Gut Microbiota and Systemic Inflammation in Older Adults". The purpose of this study is to evaluate the effects of a common over-the-counter medication, omeprazole, on the normal gut bacteria and inflammation in the body in healthy older adults.
What is the current status of trial NCT02844621?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 25 participants. The study started on 2016-05. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02844621?
The interventions under investigation include: Omeprazole (DRUG).
Who is sponsoring clinical trial NCT02844621?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.